ESR1 and breast cancer: While H3B-6545 enforces an antagonistic conformation without degrading ERα, compound 29c targets C530 covalently and engages in strong hydrophobic interactions with helix 11, demonstrating ERα degradation potency in both wild-type and ESR1-mutated BC cell lines (404).